StockNews.com assumed coverage on shares of 22nd Century Group (NASDAQ:XXII - Free Report) in a research report sent to investors on Thursday morning. The firm issued a sell rating on the biotechnology company's stock.
22nd Century Group Stock Down 11.6 %
Shares of NASDAQ:XXII traded down $0.62 during trading hours on Thursday, reaching $4.73. The stock had a trading volume of 119,675 shares, compared to its average volume of 28,288. 22nd Century Group has a 1 year low of $3.90 and a 1 year high of $581.85. The stock has a market capitalization of $219.28 million, a price-to-earnings ratio of -0.21 and a beta of 1.50. The company has a debt-to-equity ratio of 1.59, a quick ratio of 0.93 and a current ratio of 1.09. The firm's 50 day moving average is $13.39 and its 200-day moving average is $53.20.
22nd Century Group (NASDAQ:XXII - Get Free Report) last posted its quarterly earnings data on Tuesday, November 12th. The biotechnology company reported ($72.90) EPS for the quarter. 22nd Century Group had a negative return on equity of 380.39% and a negative net margin of 144.09%. The company had revenue of $5.95 million for the quarter.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in 22nd Century Group stock. Anson Funds Management LP purchased a new position in 22nd Century Group, Inc. (NASDAQ:XXII - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 3,140,452 shares of the biotechnology company's stock, valued at approximately $691,000. Anson Funds Management LP owned about 6.77% of 22nd Century Group as of its most recent filing with the Securities & Exchange Commission. Institutional investors own 18.06% of the company's stock.
22nd Century Group Company Profile
(
Get Free Report)
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
See Also
Before you consider 22nd Century Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and 22nd Century Group wasn't on the list.
While 22nd Century Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
